AUTM Newsbrief
Aug. 12, 2010

New funding should help US Patent and Trademark Office deal with backlog
American Chronicle
President Barack Obama signed an authorization for an additional $129 million to reform operations at the U.S. Patent and Trademark Office. The agency admits it has stifled American innovation and impeded the creation of millions of jobs by failing to keep up with a huge backlog of patent applications.More

Medicines, Fresenius, Genzyme, Boeing, Google, Puma: Intellectual property
Bloomberg
The patient group asked that Genzyme's exclusive license to patents 5,356,804 and 5,560,757 be opened so that "responsible entities" could use the technology to make, import, export and sell the drug. Under a provision of the 1980 Bayh-Dole Act that permits entities whose research is funded with federal dollars to retain title to inventions stemming from that research, the patients are asking that additional licenses be granted. According to the database of the U.S. Patent and Trademark Office, the two patents were issued to the Mount Sinai School of Medicine of the City University of New York.More

Plagiarism lines blur for students in digital age
The New York Times
It is a disconnect that is growing in the Internet age as concepts of intellectual property, copyright and originality are under assault in the unbridled exchange of online information, say educators who study plagiarism. Digital technology makes copying and pasting easy, of course. But that is the least of it. The Internet may also be redefining how students — who came of age with music file-sharing, Wikipedia and Web-linking — understand the concept of authorship and the singularity of any text or image. More

Gene licensing stifles research and development
Science News
Making scientific information proprietary may quash innovation, a survey of genes discovered during the last decade concludes. The analysis found that genes discovered by the biotechnology company Celera — and protected as intellectual property for up to two years — were less likely to be studied by researchers and the developers of drugs and diagnostic tests than were genes that remained in the public domain. Protecting intellectual property, whether through patents or licensing agreements, encourages private companies to invest time, energy and money in research that might never otherwise get done.More

BP assures it's committed to university research, including at the University of Illinois
The News Gazette
That's what fuel giant BP committed to in 2007 when it signed a 10-year agreement with the University of California-Berkeley, Lawrence Berkeley National Laboratory and the University of Illinois to establish a new biofuels research center. Three years in, the Energy Biosciences Institute is up and running at Berkeley, 60 researchers at the University of Illinois and 260 more in California are studying everything from miscanthus to oil-eating bacteria, and BP has spent more than $100 million on the two campuses.More

Deep brain stimulation may hold promise in Alzheimer's
Modern Medicine
The use of deep brain stimulation may provide benefits in patients with Alzheimer's disease by influencing pathological brain activity, according to research published in the Annals of Neurology. Adrian W. Laxton, M.D., of the University of Toronto, and colleagues analyzed data from six patients with mild Alzheimer's disease who underwent deep brain stimulation, with electrodes implanted near the fornix within the hypothalamus. More

Ford increases investment in university research
PR Newswire
Some of the world's brightest university professors and students are pairing up with Ford scientists in 2010 to explore a wide range of new ideas and technologies that could benefit future Ford vehicle development. Ford awarded 13 University Research Program grants to 12 different universities around the globe. More

University of Illinois at Urbana-Champaign and Sigma-Aldrich® have entered into a licensing agreement
AZoMaterials
University of Illinois at Urbana-Champaign and Sigma-Aldrich have entered into a licensing agreement which enables Sigma-Aldrich® to expand the range of a powerful class of boronic acid surrogates offered to the global chemistry community. Boronic acids are building blocks for Suzuki-Miyaura cross-couplings, one of the most widely used chemical reactions to form carbon-carbon bonds. Sigma-Aldrich plans to utilize an innovative technology developed by Professor Martin Burke of the University of Illinois at Urbana-Champaign to produce surrogates for boronic acids previously not easily accessible. More